Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C
Abstract We sought to establish a large animal model of inherited hypertrophic cardiomyopathy (HCM) with sufficient disease severity and early penetrance for identification of novel therapeutic strategies. HCM is the most common inherited cardiac disorder affecting 1 in 250–500 people, yet few thera...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-06-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-36932-5 |
_version_ | 1797789772920389632 |
---|---|
author | Joshua A. Stern Victor N. Rivas Joanna L. Kaplan Yu Ueda Maureen S. Oldach Eric S. Ontiveros Kristina B. Kooiker Sabine J. van Dijk Samantha P. Harris |
author_facet | Joshua A. Stern Victor N. Rivas Joanna L. Kaplan Yu Ueda Maureen S. Oldach Eric S. Ontiveros Kristina B. Kooiker Sabine J. van Dijk Samantha P. Harris |
author_sort | Joshua A. Stern |
collection | DOAJ |
description | Abstract We sought to establish a large animal model of inherited hypertrophic cardiomyopathy (HCM) with sufficient disease severity and early penetrance for identification of novel therapeutic strategies. HCM is the most common inherited cardiac disorder affecting 1 in 250–500 people, yet few therapies for its treatment or prevention are available. A research colony of purpose-bred cats carrying the A31P mutation in MYBPC3 was founded using sperm from a single heterozygous male cat. Cardiac function in four generations was assessed by periodic echocardiography and measurement of blood biomarkers. Results showed that HCM penetrance was age-dependent, and that penetrance occurred earlier and was more severe in successive generations, especially in homozygotes. Homozygosity was also associated with progression from preclinical to clinical disease. A31P homozygous cats represent a heritable model of HCM with early disease penetrance and a severe phenotype necessary for interventional studies aimed at altering disease progression. The occurrence of a more severe phenotype in later generations of cats, and the occasional occurrence of HCM in wildtype cats suggests the presence of at least one gene modifier or a second causal variant in this research colony that exacerbates the HCM phenotype when inherited in combination with the A31P mutation. |
first_indexed | 2024-03-13T01:55:25Z |
format | Article |
id | doaj.art-5b4799ad46954d248634d5801bbc9c0c |
institution | Directory Open Access Journal |
issn | 2045-2322 |
language | English |
last_indexed | 2024-03-13T01:55:25Z |
publishDate | 2023-06-01 |
publisher | Nature Portfolio |
record_format | Article |
series | Scientific Reports |
spelling | doaj.art-5b4799ad46954d248634d5801bbc9c0c2023-07-02T11:14:15ZengNature PortfolioScientific Reports2045-23222023-06-0113111310.1038/s41598-023-36932-5Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-CJoshua A. Stern0Victor N. Rivas1Joanna L. Kaplan2Yu Ueda3Maureen S. Oldach4Eric S. Ontiveros5Kristina B. Kooiker6Sabine J. van Dijk7Samantha P. Harris8Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California-DavisDepartment of Medicine and Epidemiology, School of Veterinary Medicine, University of California-DavisDepartment of Medicine and Epidemiology, School of Veterinary Medicine, University of California-DavisDepartment of Clinical Sciences, College of Veterinary Medicine, North Carolina State UniversityVCA Sacramento Veterinary Referral CenterRady Children’s Institute for Genomic MedicineDivision of Cardiology, Department of Medicine, University of WashingtonDepartment of Neurobiology, Physiology, and Behavior, University of California-DavisDepartment of Neurobiology, Physiology, and Behavior, University of California-DavisAbstract We sought to establish a large animal model of inherited hypertrophic cardiomyopathy (HCM) with sufficient disease severity and early penetrance for identification of novel therapeutic strategies. HCM is the most common inherited cardiac disorder affecting 1 in 250–500 people, yet few therapies for its treatment or prevention are available. A research colony of purpose-bred cats carrying the A31P mutation in MYBPC3 was founded using sperm from a single heterozygous male cat. Cardiac function in four generations was assessed by periodic echocardiography and measurement of blood biomarkers. Results showed that HCM penetrance was age-dependent, and that penetrance occurred earlier and was more severe in successive generations, especially in homozygotes. Homozygosity was also associated with progression from preclinical to clinical disease. A31P homozygous cats represent a heritable model of HCM with early disease penetrance and a severe phenotype necessary for interventional studies aimed at altering disease progression. The occurrence of a more severe phenotype in later generations of cats, and the occasional occurrence of HCM in wildtype cats suggests the presence of at least one gene modifier or a second causal variant in this research colony that exacerbates the HCM phenotype when inherited in combination with the A31P mutation.https://doi.org/10.1038/s41598-023-36932-5 |
spellingShingle | Joshua A. Stern Victor N. Rivas Joanna L. Kaplan Yu Ueda Maureen S. Oldach Eric S. Ontiveros Kristina B. Kooiker Sabine J. van Dijk Samantha P. Harris Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C Scientific Reports |
title | Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C |
title_full | Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C |
title_fullStr | Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C |
title_full_unstemmed | Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C |
title_short | Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C |
title_sort | hypertrophic cardiomyopathy in purpose bred cats with the a31p mutation in cardiac myosin binding protein c |
url | https://doi.org/10.1038/s41598-023-36932-5 |
work_keys_str_mv | AT joshuaastern hypertrophiccardiomyopathyinpurposebredcatswiththea31pmutationincardiacmyosinbindingproteinc AT victornrivas hypertrophiccardiomyopathyinpurposebredcatswiththea31pmutationincardiacmyosinbindingproteinc AT joannalkaplan hypertrophiccardiomyopathyinpurposebredcatswiththea31pmutationincardiacmyosinbindingproteinc AT yuueda hypertrophiccardiomyopathyinpurposebredcatswiththea31pmutationincardiacmyosinbindingproteinc AT maureensoldach hypertrophiccardiomyopathyinpurposebredcatswiththea31pmutationincardiacmyosinbindingproteinc AT ericsontiveros hypertrophiccardiomyopathyinpurposebredcatswiththea31pmutationincardiacmyosinbindingproteinc AT kristinabkooiker hypertrophiccardiomyopathyinpurposebredcatswiththea31pmutationincardiacmyosinbindingproteinc AT sabinejvandijk hypertrophiccardiomyopathyinpurposebredcatswiththea31pmutationincardiacmyosinbindingproteinc AT samanthapharris hypertrophiccardiomyopathyinpurposebredcatswiththea31pmutationincardiacmyosinbindingproteinc |